ES2048137T1 - Metodo y compuesto para el tratamiento de infeccion hiv en mamiferos. - Google Patents

Metodo y compuesto para el tratamiento de infeccion hiv en mamiferos.

Info

Publication number
ES2048137T1
ES2048137T1 ES91900012T ES91900012T ES2048137T1 ES 2048137 T1 ES2048137 T1 ES 2048137T1 ES 91900012 T ES91900012 T ES 91900012T ES 91900012 T ES91900012 T ES 91900012T ES 2048137 T1 ES2048137 T1 ES 2048137T1
Authority
ES
Spain
Prior art keywords
treatment
mammals
compound
hiv infection
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES91900012T
Other languages
English (en)
Other versions
ES2048137T3 (es
Inventor
Erfle Volker
Torben Saermark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Original Assignee
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH filed Critical Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Publication of ES2048137T1 publication Critical patent/ES2048137T1/es
Application granted granted Critical
Publication of ES2048137T3 publication Critical patent/ES2048137T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Insects & Arthropods (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE DESCRIBEN UN METODO Y UNA COMPOSICION PARA EL TRATAMIENTO DE LAS INFECCIONES CAUSADAS POR EL VIH EN MAMIFEROS QUE CONSISTE EN LA ADMINISTRACION DE UNA DOSIS SUBTOXICA EFECTIVA DE MELITINA AL MAMIFERO CON LO QUE SE INHIBE EL CRECIMIENTO DE LAS CELULAS INFECTADAS POR EL VIH O LA REPRODUCCION DEL VIRUS EN LAS CELULAS INFECTADAS DEL MAMIFERO.
ES91900012T 1989-12-07 1990-12-07 Metodo y compuesto para el tratamiento de una infeccion hiv en mamiferos. Expired - Lifetime ES2048137T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3940526 1989-12-07

Publications (2)

Publication Number Publication Date
ES2048137T1 true ES2048137T1 (es) 1994-03-16
ES2048137T3 ES2048137T3 (es) 1994-10-16

Family

ID=6395034

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91900012T Expired - Lifetime ES2048137T3 (es) 1989-12-07 1990-12-07 Metodo y compuesto para el tratamiento de una infeccion hiv en mamiferos.

Country Status (11)

Country Link
EP (1) EP0504191B1 (es)
JP (1) JPH075475B2 (es)
KR (1) KR970005329B1 (es)
AT (1) ATE110278T1 (es)
AU (1) AU646652B2 (es)
BR (1) BR9007904A (es)
DE (2) DE69011870T2 (es)
DK (1) DK0504191T3 (es)
ES (1) ES2048137T3 (es)
GR (1) GR930300031T1 (es)
WO (1) WO1991008753A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770688A (en) * 1989-12-07 1998-06-23 Gsf-Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Method and composition for the treatment of mammalian HIV infection
DK82892D0 (da) * 1992-06-24 1992-06-24 Michael Hansen Anvendelse af braadgifte fra bier og hvepse til fremstilling af laegemidler til behandling af infektioner
WO1996028563A1 (en) * 1995-03-09 1996-09-19 Bavarian Nordic Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
WO1999018983A1 (en) * 1997-10-15 1999-04-22 Alk-Abelló A/S Composition and method for treating an encephalomyelopathic, demyelinating or autoimmune disease
WO2012093068A1 (en) * 2011-01-03 2012-07-12 F. Hoffmann-La Roche Ag A pharmaceutical composition of a complex of an anti-dig antibody and digoxigenin that is conjugated to a peptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856936A (en) * 1973-05-07 1974-12-24 Schuyler Dev Corp Composition and method for cortisol control

Also Published As

Publication number Publication date
WO1991008753A1 (en) 1991-06-27
EP0504191B1 (en) 1994-08-24
AU646652B2 (en) 1994-03-03
JPH075475B2 (ja) 1995-01-25
GR930300031T1 (en) 1993-06-07
DE69011870D1 (de) 1994-09-29
ES2048137T3 (es) 1994-10-16
AU6880891A (en) 1991-07-18
EP0504191A1 (en) 1992-09-23
DE504191T1 (de) 1993-04-08
KR970005329B1 (ko) 1997-04-15
BR9007904A (pt) 1992-09-29
DK0504191T3 (da) 1995-03-27
ATE110278T1 (de) 1994-09-15
JPH05504761A (ja) 1993-07-22
DE69011870T2 (de) 1994-12-15

Similar Documents

Publication Publication Date Title
ES2188656T3 (es) Composicion antiviral para la cicatrizacion de una herida que contiene un piruvato, un antioxidante, una mezcla de acidos grasos saturados y un compuesto antiviral.
ES541103A0 (es) Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales
FI931097A0 (fi) Laekemedel, deras framstaellning och anvaendning vid bekaempning av smaertor och/eller inflammationen hos maenniskor och djur
DK143088D0 (da) Praeparat til behandling eller forhindring af virale infektioner
RU94022480A (ru) Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с
SE8504967L (sv) Farmaceutisk komposition och forfarande for behandling av kroppen
DK109487A (da) Fungicid paa basis af et cyanopyrrolderivat
SE8406538D0 (sv) Novel derivatives of purine
GR3017128T3 (en) Treatment of hiv infections and compounds useful therein.
ES2133289T3 (es) Aumento en los niveles de glutation con glutamina.
DK538888D0 (da) Anvendelse af castanosperminestere til fremstilling af et farmaceutisk praeparat
ES2048137T1 (es) Metodo y compuesto para el tratamiento de infeccion hiv en mamiferos.
SE8605503D0 (sv) Novel medicinal use
DK0484112T3 (da) Anvendelse af lithium ved behandlingen eller profylakse af Molluscum contagiosum
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
DE69019404D1 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
ATE92760T1 (de) Verwendung des thiazol-derivates tiprotimod zur herstellung eines mittels zur therapie von virusinfektionen.
ATE155795T1 (de) Verwendung von leukoregulin zur behandlung von mit einem envelope-virus infizierten tier
SE8804640D0 (sv) Medicament comprising cyclolinopeptide a
KR910000182A (ko) 항바이러스성 약제학적 조성물
MX9307639A (es) Metodo para tratar infecciones virales con terapia conjuntiva con compuestos similares al aciclovir y un analogo de nucleosido 2'-viril substituido.
MC2306A1 (fr) Peptides bloquant les infections par le virus de l'immunodeficience humaine et methode de leur utilisation
EP0400312A3 (en) Method and composition for treating protozoal infections with a novel antibacterial agent
Richtsmeier The interferons

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 504191

Country of ref document: ES